Biomacromolecules. 2023 Oct 9;24(10):4465-4477. doi: 10.1021/acs.biomac.2c01289. Epub 2023 Jan 23.
Bioemulsions are attractive platforms for the scalable expansion of adherent cells and stem cells. In these systems, cell adhesion is enabled by the assembly of protein nanosheets that display high interfacial shear moduli and elasticity. However, to date, most successful systems reported to support cell adhesion at liquid substrates have been based on coassemblies of protein and reactive cosurfactants, which limit the translation of bioemulsions. In this report, we describe the design of protein nanosheets based on two globular proteins, bovine serum albumin (BSA) and β-lactoglobulin (BLG), biofunctionalized with RGDSP peptides to enable cell adhesion. The interfacial mechanics of BSA and BLG assemblies at fluorinated liquid-water interfaces is studied by interfacial shear rheology, with and without cosurfactant acyl chloride. Conformational changes associated with globular protein assembly are studied by circular dichroism and protein densities at fluorinated interfaces are evaluated via surface plasmon resonance. Biofunctionalization mediated by sulfo-succinimidyl 4-(-maleimidomethyl) cyclohexane-1-carboxylate (sulfo-SMCC) is studied by fluorescence microscopy. On the basis of the relatively high elasticities observed in the case of BLG nanosheets, even in the absence of cosurfactant, the adhesion and proliferation of mesenchymal stem cells and human embryonic kidney (HEK) cells on bioemulsions stabilized by RGD-functionalized protein nanosheets is studied. To account for the high cell spreading and proliferation observed at these interfaces, despite initial moderate interfacial elasticities, the deposition of fibronectin fibers at the surface of corresponding microdroplets is characterized by immunostaining and confocal microscopy. These results demonstrate the feasibility of achieving high cell proliferation on bioemulsions with protein nanosheets assembled without cosurfactants and establish strategies for rational design of scaffolding proteins enabling the stabilization of interfaces with strong shear mechanics and elasticity, as well as bioactive and cell adhesive properties. Such protein nanosheets and bioemulsions are proposed to enable the development of new generations of bioreactors for the scale up of cell manufacturing.
生物乳剂是一种有吸引力的平台,可以实现贴壁细胞和干细胞的规模化扩增。在这些系统中,通过组装具有高界面剪切模量和弹性的蛋白质纳米片来实现细胞黏附。然而,迄今为止,大多数成功报道的支持液体基底上细胞黏附的系统都是基于蛋白质和反应性助表面活性剂的共组装,这限制了生物乳剂的转化。在本报告中,我们描述了基于两种球状蛋白质(牛血清白蛋白(BSA)和β-乳球蛋白(BLG))设计的蛋白质纳米片,这些蛋白质纳米片经过 RGDSP 肽的生物功能化以实现细胞黏附。通过界面剪切流变学研究了 BSA 和 BLG 组装在氟化液-水界面上的界面力学,有无助表面活性剂酰氯。通过圆二色性研究了与球状蛋白质组装相关的构象变化,并通过表面等离子体共振评估了氟化界面处的蛋白质密度。通过荧光显微镜研究了通过磺基琥珀酰亚胺基 4-(-马来酰亚胺基甲基)环己烷-1-羧酸盐(sulfo-SMCC)介导的生物功能化。基于在 BLG 纳米片中观察到的相对较高的弹性,即使在没有助表面活性剂的情况下,研究了 RGD 功能化蛋白质纳米片稳定的生物乳剂上间充质干细胞和人胚肾(HEK)细胞的黏附和增殖。为了说明在这些界面上观察到的高细胞扩展和增殖,尽管初始界面弹性适中,通过免疫染色和共聚焦显微镜研究了相应微滴表面纤维连接蛋白纤维的沉积。这些结果表明,在没有助表面活性剂的情况下,使用蛋白质纳米片组装实现高细胞增殖的生物乳剂是可行的,并为实现具有强剪切力学和弹性以及生物活性和细胞黏附性的支架蛋白的合理设计策略奠定了基础。这些蛋白质纳米片和生物乳剂有望为细胞制造的规模化发展提供新一代生物反应器。